| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/JCP.48.6.531 |
| P953 | full work available at URL | https://jcp.bmj.com/content/48/6/531.full.pdf |
| https://europepmc.org/articles/PMC502682 | ||
| https://europepmc.org/articles/PMC502682?pdf=render | ||
| https://syndication.highwire.org/content/doi/10.1136/jcp.48.6.531 | ||
| P932 | PMC publication ID | 502682 |
| P698 | PubMed publication ID | 7665695 |
| P5875 | ResearchGate publication ID | 15532853 |
| P2093 | author name string | J. B. Nousbaum | |
| M. Robaszkiewicz | |||
| H. Gouérou | |||
| A. Volant | |||
| C. Férec | |||
| M. A. Giroux | |||
| I. Roué-Quintin | |||
| J. P. Metges | |||
| P2860 | cites work | Barrett's esophagus | Q69885120 |
| Precursors of gastric and esophageal cancer | Q70507867 | ||
| Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas | Q72209522 | ||
| p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study | Q72638571 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Frequent mutation of the p53 gene in human esophageal cancer | Q33927516 | ||
| Research on esophageal cancer in China: a review. | Q34275018 | ||
| p53 function and dysfunction | Q35721291 | ||
| Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction | Q37527489 | ||
| p53 gene mutations in Barrett's epithelium and esophageal cancer | Q38488725 | ||
| Clinical implications of the p53 tumor-suppressor gene | Q40865658 | ||
| Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form | Q41210647 | ||
| Expression of p53 in premalignant and malignant squamous epithelium. | Q41663602 | ||
| p53 expression in colorectal adenomas | Q41873922 | ||
| Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. | Q42510940 | ||
| Treatment of and survival after epidermoid cancer of the esophagus in the department of Finistère between 1984 and 1988 (716 cases) | Q43639523 | ||
| Esophageal cancer in Ille-et-Vilaine in relation to levels of alcohol and tobacco consumption. Risks are multiplying | Q43800400 | ||
| Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. | Q44248378 | ||
| Expression of the nuclear oncogene p53 in colon tumours | Q44688679 | ||
| TP53 gene mutation profile in esophageal squamous cell carcinomas. | Q46700391 | ||
| Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations | Q53497225 | ||
| Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies | Q60200233 | ||
| p53 mutation and protein accumulation during multistage human esophageal carcinogenesis | Q67904412 | ||
| Maintenance of p53 alterations throughout breast cancer progression | Q67915702 | ||
| Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers | Q67920829 | ||
| Precursor lesions of esophageal cancer in high-risk populations in Henan Province, China | Q68433148 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 531-534 | |
| P577 | publication date | 1995-06-01 | |
| P1433 | published in | Journal of Clinical Pathology | Q6294965 |
| P1476 | title | p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesions | |
| P478 | volume | 48 |
| Q41905212 | A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion |
| Q37504800 | Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma |
| Q41376475 | Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors |
| Q37218207 | Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus |
| Q33591112 | Insulin-like growth factor-binding protein-3 promotes transforming growth factor-{beta}1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells |
| Q42028034 | Notch receptor inhibition reveals the importance of cyclin D1 and Wnt signaling in invasive esophageal squamous cell carcinoma. |
| Q42471426 | Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions |
| Q37640813 | p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival |
| Q38474715 | p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium. |
Search more.